Karen J. Wilson
Independent Non-Executive DirectorMs. Karen J. Wilson, CPA, is an Independent Director of Serina Therapeutics, Inc. from January 2025. She serves as an Independent Non-Executive Director at Lava Therapeutics N. V. since March 2021. She served as an Independent Director of Vaxart, Inc. since August 25, 2020 until August 04, 2022. She has been an Independent Non-Executive Director at Connect Biopharma Holdings Limited since December 2020. She was Senior Vice President, Finance of Jazz Pharmaceuticals plc (formerly known as Jazz Pharmaceuticals, Inc.) until September 2020. Ms. Wilson is also an Independent Non-Employee Director for Angion Biomedica Board of Directors since April 2020. She served as the Principal Accounting Officer of Jazz Pharmaceuticals plc (formerly known as Jazz Pharmaceuticals, Inc.) since January 18, 2012 and served as its Senior Vice President of Finance since February 2013. She joined Jazz Pharmaceuticals organization in February 2011. Ms. Wilson is a biopharmaceutical finance executive and Board Member with industry and leadership experience in life science companies across finance, strategy and risk management. Ms. Wilson served as Vice President of Finance and Principal Accounting Officer at Azur Pharma Limited. Ms. Wilson served as Vice President of Finance at Jazz Pharmaceuticals plc (formerly known as Jazz Pharmaceuticals, Inc.) from March 9, 2011 to February 2013. She served as Principal Accounting Officer and Vice President of Finance at PDL BioPharma, Inc., from April 22, 2009 to January 31, 2011. She serves as Independent Director of Elicio Therapeutics, Inc. (formerly Angion Biomedica) since June 1, 2023. She also previously served as a Principal at the consulting firm of Wilson Crisler LLC. Ms. Wilson served as the Chief Financial Officer of Monogram Biosciences, Inc. (formerly Virologic Inc.) from January 2001 to 2004 and served as its Vice President and Principal Accounting Officer. From 2005 to 2009, she was a Principal at the consulting firm Wilson Crisler LLC. From November 1999 to January 2001, she served as the Chief Financial Officer and Vice President of Operations at Novare Surgical Systems, Inc., a medical device manufacturer. From 1987 to 1993 and from 1996 to November 1999, she served for Deloitte & Touche LLP, a professional services firm and served as a Senior Manager serving a diverse list of global clients in both the medical and technology fields. From 1993 to 1996, she was Controller for Lightwave Electronics Corporation, a laser manufacturer. Ms. Wilson is a Certified Public Accountant and has B. S. in Business from the University of California at Berkeley.
Positions
- Company NameConnect Biopharma Holdings LimitedStock CodeCNTBPositionIndependent Non-Executive DirectorColleagues
- BDBarry David QuartCEO & Director
- KGKleanthis G. XanthopoulosIndependent Chairman
- DLDavid L. SzekeresPresident
- LPLisa PerazaSenior Vice President of Finance
- JCJeff CohnGeneral Counsel & Corporate Secretary
- STSean T. RistineVice President of Human Resources
- KJKaren J. WilsonIndependent Non-Executive Director
- JIJean I. LiuIndependent Director
- BGBrian Gordon FeaganMember of Scientific Advisory Board
- Company NameSerina Therapeutics, Inc.Stock CodeSERPositionIndependent DirectorColleagues
- BGBalkrishan GillExecutive Co-Chairman of the Board
- GHGregory H. BaileyIndependent Co-Chairman of the Board of Directors
- SASteven A. LedgerCEO & Director
- JMJ. Milton HarrisCo-Founder, Director Emeritus & Chair of Scientific Advisory Board
- STSrini TenjarlaChief Technical Operations Officer
- RWRandall W. MoreadithChief Development Officer
